Vedolizumab Relieves Refractory Crohn ' s Disease Vedolizumab Relieves Refractory Crohn ' s Disease

The monoclonal antibody helps some patients with Crohn ' s disease, according to the VERSIFY study, which builds on findings from the GEMINI 2 and 3 trials.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news